1. FDA grants priority review to Roche's lung cancer drug Tecentriq — Teva drug fails in pediatric Tourette syndrome trial — GSK pays $50M for two solid tumor cell therapies from Immatics — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Create Thread

Anonymous board for Eyetech Pharmaceuticals

Verification:

(CustomImgCaptcha By Surrey Forum)

Tags:

Multiple tags may be separated by commas.

Post a Poll

Possible Responses:
Maximum Selectable Responses:

This is the maximum number of responses a voter may select when voting.

Options: